Bayer’s Pharmaceuticals Research & Development division is working on potential future therapies for patients with cardiovascular diseases.
In order to develop tailored therapeutic approaches, it is necessary to have patient samples and data in order to identify patient relevant targets or pathomechanisms.
We are seeking ventricular heart tissue samples and linked clinical data from patients with end-stage heart failure. We are seeking partnerships with both fee-for-service providers and also academic and public institutions who could provide such material and clinical data.
Deadline: May 31, 2024